Almehizia, A.A.; Naglah, A.M.; Aljafen, S.S.; Hassan, A.S.; Aboulthana, W.M.
Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent. Pharmaceutics 2025, 17, 180.
https://doi.org/10.3390/pharmaceutics17020180
AMA Style
Almehizia AA, Naglah AM, Aljafen SS, Hassan AS, Aboulthana WM.
Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent. Pharmaceutics. 2025; 17(2):180.
https://doi.org/10.3390/pharmaceutics17020180
Chicago/Turabian Style
Almehizia, Abdulrahman A., Ahmed M. Naglah, Sadeem S. Aljafen, Ashraf S. Hassan, and Wael M. Aboulthana.
2025. "Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent" Pharmaceutics 17, no. 2: 180.
https://doi.org/10.3390/pharmaceutics17020180
APA Style
Almehizia, A. A., Naglah, A. M., Aljafen, S. S., Hassan, A. S., & Aboulthana, W. M.
(2025). Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent. Pharmaceutics, 17(2), 180.
https://doi.org/10.3390/pharmaceutics17020180
